GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently becoming a major focus in therapeutic research, largely due to its remarkable impact on managing ailments such as type 2 diabetes and obesity. New studies have shown that more than glucose management, GLP-1 drugs offer benefits for heart well-being and possibly neurodegenerati